Epocrates gets the bulk of its revenues by charging pharmaceutical companies to engage with its doctors.

FORBES: New Epocrates CEO Has A Tough Job Ahead of Him

Patients receive the bulk of their points at refill, and rewards are determined by the pharmaceutical company.

FORBES: Drug Companies Need To Push For Medication Adherence